These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 24937139

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX, Shi YN, Teng LS, Li X, Wang LX, Meng QF, Teng LR, Li YX.
    Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
    Dillen K, Vandervoort J, Van den Mooter G, Ludwig A.
    Int J Pharm; 2006 May 11; 314(1):72-82. PubMed ID: 16600538
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery.
    Feng R, Zhang Z, Li Z, Huang G.
    Drug Deliv; 2014 May 11; 21(3):185-92. PubMed ID: 24107001
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
    Bozdag S, Dillen K, Vandervoort J, Ludwig A.
    J Pharm Pharmacol; 2005 Jun 11; 57(6):699-707. PubMed ID: 15969924
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
    Gasparini G, Kosvintsev SR, Stillwell MT, Holdich RG.
    Colloids Surf B Biointerfaces; 2008 Feb 15; 61(2):199-207. PubMed ID: 17919891
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. PLGA/mesoporous silica hybrid structure for controlled drug release.
    Xue JM, Shi M.
    J Control Release; 2004 Aug 11; 98(2):209-17. PubMed ID: 15262413
    [Abstract] [Full Text] [Related]

  • 16. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
    Yang Y, Gao Y, Mei X.
    Pharm Dev Technol; 2013 Aug 11; 18(5):1169-74. PubMed ID: 21967467
    [Abstract] [Full Text] [Related]

  • 17. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres.
    Yang F, Song FL, Pan YF, Wang ZY, Yang YQ, Zhao YM, Liang SZ, Zhang YM.
    J Microencapsul; 2010 Aug 11; 27(2):133-41. PubMed ID: 20121486
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A, Siegel SJ, Winey KI.
    Int J Pharm; 2007 May 24; 336(2):367-75. PubMed ID: 17207944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.